The study is intended to test the safety, tolerability, and efficacy of long-term treatment with YM178 in patients with overactive bladder symptoms.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
204
Oral
Unnamed facility
Kansai, Japan
Unnamed facility
Kantou, Japan
Vital signs, AEs, lab tests, ECG, post-void residual volume
Time frame: 52 weeks
Changes from baseline in the mean number of micturitions/24hrs
Time frame: 52 weeks
Changes from baseline in the mean number of urinary urgencies/24 hrs
Time frame: 52 weeks
Changes from baseline in the mean number of incontinence episodes/24 hrs
Time frame: 52 weeks
Changes from baseline in the mean number of urge incontinence episodes/24 hrs
Time frame: 52 weeks
Changes from baseline in the mean number of nocturnal urinations
Time frame: 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.